AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mensink, R. P
Right arrow Articles by Hornstra, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mensink, R. P
Right arrow Articles by Hornstra, G.
Agricola
Right arrow Articles by Mensink, R. P
Right arrow Articles by Hornstra, G.
American Journal of Clinical Nutrition, Vol. 69, No. 2, 213-219, February 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mildly elevated serum lipid concentrations1,2,3

Ronald P Mensink, Adriana C van Houwelingen, Daan Kromhout and Gerard Hornstra

Background: Tocotrienols, lipid-soluble antioxidants with vitamin E activity, have been reported to lower LDL-cholesterol concentrations and platelet aggregation in men, but results are contradictory.

Objective: To examine in detail the effects of a vitamin E concentrate rich in tocotrienols on serum lipoproteins and on platelet function in men at risk for cardiovascular disease.

Design: In this randomized, double-blind, placebo-controlled parallel trial, 20 men received daily for 6 wk 4 capsules, each containing 35 mg tocotrienols and 20 mg {alpha}-tocopherol; 20 other men received 4 capsules daily, each providing 20 mg {alpha}-tocopherol. All men had concentrations of serum total cholesterol between 6.5 and 8.0 mmol/L or lipoprotein(a) concentrations >150 mg/L.

Results: Compliance was confirmed by changes in serum tocopherol and tocotrienol concentrations. Serum LDL cholesterol in the tocotrienol group was 4.80 mmol/L before and 4.79 mmol/L after intervention, and increased from 4.70 to 4.86 mmol/L in the placebo group (95% CI for the difference: -0.54, 0.19 mmol/L; P = 0.333). Also, changes in HDL cholesterol, triacylglycerol, lipoprotein(a), and lipid peroxide concentrations did not differ between the groups. After adjustment for differences in initial values, no effects were found on collagen-induced platelet aggregation velocity, maximum aggregation, or thromboxane B2 formation in citrated whole blood. ATP release, however, was lower in the tocotrienol group. Urinary thromboxane B2 and 11-keto-thromboxane B2 concentrations and coagulation and fibrinolytic measures did not change.

Conclusion: The tocotrienol supplements used had no marked favorable effects on the serum lipoprotein profile or on platelet function in men with slightly elevated lipid concentrations.

Key Words: Tocotrienols • cholesterol • HDL cholesterol • triacylglycerols • aggregation • coagulation • fibrinolysis • lipid peroxides • humans • thromboxane B2 • platelets




This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
J. Arnaud, M. Bost, D. Vitoux, J. Labarere, P. Galan, H. Faure, S. Hercberg, J.-C. Bordet, A.-M. Roussel, and P. Chappuis
Effect of Low Dose Antioxidant Vitamin and Trace Element Supplementation on the Urinary Concentrations of Thromboxane and Prostacyclin Metabolites
J. Am. Coll. Nutr., October 1, 2007; 26(5): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Fairus, R. M Nor, H. M Cheng, and K. Sundram
Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of {alpha}-tocopherol.
Am. J. Clinical Nutrition, October 1, 2006; 84(4): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Schaffer, W. E. Muller, and G. P. Eckert
Tocotrienols: Constitutional Effects in Aging and Disease
J. Nutr., February 1, 2005; 135(2): 151 - 154.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
C. K. SEN, S. KHANNA, and S. ROY
Tocotrienol: The Natural Vitamin E to Defend the Nervous System?
Ann. N.Y. Acad. Sci., December 1, 2004; 1031(1): 127 - 142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
V. A Mustad, C. A Smith, P. P Ruey, N. K Edens, and S. J DeMichele
Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia
Am. J. Clinical Nutrition, December 1, 2002; 76(6): 1237 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. A.J.M. Kerckhoffs, F. Brouns, G. Hornstra, and R. P. Mensink
Effects on the Human Serum Lipoprotein Profile of {beta}-Glucan, Soy Protein and Isoflavones, Plant Sterols and Stanols, Garlic and Tocotrienols
J. Nutr., September 1, 2002; 132(9): 2494 - 2505.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. Packer, S. U. Weber, and G. Rimbach
Molecular Aspects of {{alpha}}-Tocotrienol Antioxidant Action and Cell Signalling
J. Nutr., February 1, 2001; 131(2): 369S - 373.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
T. M. Black, P. Wang, N. Maeda, and R. A. Coleman
Palm Tocotrienols Protect ApoE +/- Mice from Diet-Induced Atheroma Formation
J. Nutr., October 1, 2000; 130(10): 2420 - 2426.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition